• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Varian domestic orders flatten

Article

Varian Medical Systems stock got clobbered July 14, dropping nearly $8 per share to about $67, after the company reported that orders for oncology equipment from North American customers were flat in the fiscal third quarter. The announcement was made

Varian Medical Systems stock got clobbered July 14, dropping nearly $8 per share to about $67, after the company reported that orders for oncology equipment from North American customers were flat in the fiscal third quarter. The announcement was made ahead of the scheduled July 29 earnings release in response to high-volume, volatile trading. The knee-jerk reaction to the announcement reflects the importance of the U.S. market, as it was swaddled in otherwise good news-an expected 30% jump in overall earnings on a 14% rise in sales per share for the third quarter compared with the previous year's period.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.